Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2003 Sep;79(935):511–515. doi: 10.1136/pmj.79.935.511

Giant cell arteritis

J Calvo-Romero
PMCID: PMC1742823  PMID: 13679546

Abstract

Giant cell arteritis (GCA), temporal arteritis or Horton's arteritis, is a systemic vasculitis which involves large and medium sized vessels, especially the extracranial branches of the carotid arteries, in persons usually older than 50 years. Permanent visual loss, ischaemic strokes, and thoracic and abdominal aortic aneurysms are feared complications of GCA. The treatment consists of high dose steroids. Mortality, with a correct treatment, in patients with GCA seems to be similar that of controls.

Full Text

The Full Text of this article is available as a PDF (74.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Achkar A. A., Lie J. T., Gabriel S. E., Hunder G. G. Giant cell arteritis involving the facial artery. J Rheumatol. 1995 Feb;22(2):360–362. [PubMed] [Google Scholar]
  2. Achkar A. A., Lie J. T., Hunder G. G., O'Fallon W. M., Gabriel S. E. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med. 1994 Jun 15;120(12):987–992. doi: 10.7326/0003-4819-120-12-199406150-00003. [DOI] [PubMed] [Google Scholar]
  3. Adachi J. D., Saag K. G., Delmas P. D., Liberman U. A., Emkey R. D., Seeman E., Lane N. E., Kaufman J. M., Poubelle P. E., Hawkins F. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum. 2001 Jan;44(1):202–211. doi: 10.1002/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W. [DOI] [PubMed] [Google Scholar]
  4. Altiparmak M. R., Tabak F., Pamuk O. N., Pamuk G. E., Mert A., Aktuğlu Y. Giant cell arteritis and secondary amyloidosis: the natural history. Scand J Rheumatol. 2001;30(2):114–116. doi: 10.1080/03009740151095448. [DOI] [PubMed] [Google Scholar]
  5. Amor-Dorado Juan C., Llorca Javier, Garcia-Porrua Carlos, Costa Carmen, Perez-Fernandez Nicolas, Gonzalez-Gay Miguel A. Audiovestibular manifestations in giant cell arteritis: a prospective study. Medicine (Baltimore) 2003 Jan;82(1):13–26. doi: 10.1097/00005792-200301000-00002. [DOI] [PubMed] [Google Scholar]
  6. Armona J., Rodríguez-Valverde V., González-Gay M. A., Figueroa M., Fernández-Sueiro J. L., Blanco R., Martínez-Taboada V. Arteritis de células gigantes. Estudio de 191 pacientes. Med Clin (Barc) 1995 Dec 2;105(19):734–737. [PubMed] [Google Scholar]
  7. Baldursson O., Steinsson K., Björnsson J., Lie J. T. Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum. 1994 Jul;37(7):1007–1012. doi: 10.1002/art.1780370705. [DOI] [PubMed] [Google Scholar]
  8. Barrier J., Pion P., Massari R., Peltier P., Rojouan J., Grolleau J. Y. Approche épidémiologique de la maladie de Horton dans le département de Loire-Atlantique. 110 cas en 10 ans (1970-1979). Rev Med Interne. 1982 Mar;3(1):13–20. doi: 10.1016/s0248-8663(82)80003-9. [DOI] [PubMed] [Google Scholar]
  9. Becourt-Verlomme C., Barouky R., Alexandre C., Gonthier R., Laurent H., Vital Durand D., Rousset H. Symptômes inauguraux de la maladie de Horton sur une série de 260 patients. Rev Med Interne. 2001 Jul;22(7):631–637. doi: 10.1016/s0248-8663(01)00400-3. [DOI] [PubMed] [Google Scholar]
  10. Bengtsson B. A., Malmvall B. E. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. Arthritis Rheum. 1981 Jul;24(7):899–904. doi: 10.1002/art.1780240706. [DOI] [PubMed] [Google Scholar]
  11. Blumberg S., Giansiracusa D. F., Docken W. P., Kantrowitz F. G. Recurrence of temporal arteritis. Clinical recurrence nine years after initial illness. JAMA. 1980 Oct 10;244(15):1713–1713. [PubMed] [Google Scholar]
  12. Brack A., Martinez-Taboada V., Stanson A., Goronzy J. J., Weyand C. M. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum. 1999 Feb;42(2):311–317. doi: 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  13. Cacoub P., Chemlal K., Khalifa P., Wechsler B., De Gennes C., Belmatoug N., Cohen P., Ziza J. M., Verdoncq B., Piette J. C. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss. J Rheumatol. 2001 Nov;28(11):2474–2479. [PubMed] [Google Scholar]
  14. Calvo Romero J. M., Magro Ledesma D., Ramos Salado J. L., Bureo Dacal J. C., de Dios Arrebola García J., Bureo Dacal P., Pérez Miranda M. Arteritis de células gigantes: un estudio descriptivo en el suroeste de España. An Med Interna. 2000 Feb;17(2):67–70. [PubMed] [Google Scholar]
  15. Cantini F., Niccoli L., Salvarani C., Padula A., Olivieri I. Treatment of longstanding active giant cell arteritis with infliximab: report of four cases. Arthritis Rheum. 2001 Dec;44(12):2933–2935. doi: 10.1002/1529-0131(200112)44:12<2933::aid-art482>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  16. Caselli R. J., Daube J. R., Hunder G. G., Whisnant J. P. Peripheral neuropathic syndromes in giant cell (temporal) arteritis. Neurology. 1988 May;38(5):685–689. doi: 10.1212/wnl.38.5.685. [DOI] [PubMed] [Google Scholar]
  17. Caselli R. J. Giant cell (temporal) arteritis: a treatable cause of multi-infarct dementia. Neurology. 1990 May;40(5):753–755. doi: 10.1212/wnl.40.5.753. [DOI] [PubMed] [Google Scholar]
  18. Chakrabarty A., Franks A. J. Temporal artery biopsy: is there any value in examining biopsies at multiple levels? J Clin Pathol. 2000 Feb;53(2):131–136. doi: 10.1136/jcp.53.2.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Chan C. C., Paine M., O'Day J. Steroid management in giant cell arteritis. Br J Ophthalmol. 2001 Sep;85(9):1061–1064. doi: 10.1136/bjo.85.9.1061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Chevalet P., Barrier J. H., Glémarec J., el Kouri D., Hamidou M., de Wazières B., Duhamel E., Jégo P., Maugars Y., Planchon B. Maladie de Horton du sujet âgé de plus de 75 ans: particularites évolutives, complications de la corticothérapie. Etude comparative sur une série de 164 patients. Vers une dose d'attaque réduite. Rev Med Interne. 2001 Jul;22(7):624–630. doi: 10.1016/s0248-8663(01)00399-x. [DOI] [PubMed] [Google Scholar]
  21. Chevalet P., Barrier J. H., Pottier P., Magadur-Joly G., Pottier M. A., Hamidou M., Planchon B., El Kouri D., Connan L., Dupond J. L. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients. J Rheumatol. 2000 Jun;27(6):1484–1491. [PubMed] [Google Scholar]
  22. Chowdhry Iftikhar Ahmad, Sinha Jayashree, Barland Peter. Brachial plexopathy as a presenting symptom of giant cell arteritis. J Rheumatol. 2002 Dec;29(12):2653–2657. [PubMed] [Google Scholar]
  23. Cid M. C., Font C., Oristrell J., de la Sierra A., Coll-Vinent B., López-Soto A., Vilaseca J., Urbano-Márquez A., Grau J. M. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum. 1998 Jan;41(1):26–32. doi: 10.1002/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  24. Cornblath W. T., Eggenberger E. R. Progressive visual loss from giant cell arteritis despite high-dose intravenous methylprednisolone. Ophthalmology. 1997 May;104(5):854–858. doi: 10.1016/s0161-6420(97)30222-x. [DOI] [PubMed] [Google Scholar]
  25. Dababneh A., Gonzalez-Gay M. A., Garcia-Porrua C., Hajeer A., Thomson W., Ollier W. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J Rheumatol. 1998 Nov;25(11):2140–2145. [PubMed] [Google Scholar]
  26. De Keyser J., De Klippel N., Ebinger G. Thrombocytosis and ischaemic complications in giant cell arteritis. BMJ. 1991 Oct 5;303(6806):825–825. doi: 10.1136/bmj.303.6806.825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Duhaut P., Berruyer M., Pinede L., Demolombe-Rague S., Loire R., Seydoux D., Dechavanne M., Ninet J., Pasquier J. Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. Arthritis Rheum. 1998 Apr;41(4):701–709. doi: 10.1002/1529-0131(199804)41:4<701::AID-ART18>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  28. Duhaut P., Bosshard S., Calvet A., Pinede L., Demolombe-Rague S., Dumontet C., Loire R., Seydoux D., Ninet J., Pasquier J. Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. J Rheumatol. 1999 Feb;26(2):361–369. [PubMed] [Google Scholar]
  29. Elling P., Olsson A. T., Elling H. A reduced CD8+ lymphocyte subset distinguishes patients with polymyalgia rheumatica and temporal arteritis from patients with other diseases. Clin Exp Rheumatol. 1998 Mar-Apr;16(2):155–160. [PubMed] [Google Scholar]
  30. Elling P., Olsson A. T., Elling H. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. J Rheumatol. 1996 Jan;23(1):112–119. [PubMed] [Google Scholar]
  31. Evans J. M., Bowles C. A., Bjornsson J., Mullany C. J., Hunder G. G. Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases. Arthritis Rheum. 1994 Oct;37(10):1539–1547. doi: 10.1002/art.1780371020. [DOI] [PubMed] [Google Scholar]
  32. Evans J. M., Hunder G. G. Polymyalgia rheumatica and giant cell arteritis. Rheum Dis Clin North Am. 2000 Aug;26(3):493–515. doi: 10.1016/s0889-857x(05)70153-8. [DOI] [PubMed] [Google Scholar]
  33. Evans J. M., O'Fallon W. M., Hunder G. G. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med. 1995 Apr 1;122(7):502–507. doi: 10.7326/0003-4819-122-7-199504010-00004. [DOI] [PubMed] [Google Scholar]
  34. Fietta Pieranna, Manganelli Paolo, Zanetti Adele, Neri Tauro Maria. Familial giant cell arteritis and polymyalgia rheumatica: aggregation in 2 families. J Rheumatol. 2002 Jul;29(7):1551–1555. [PubMed] [Google Scholar]
  35. Foroozan Rod, Danesh-Meyer Helen, Savino Peter J., Gamble Greg, Mekari-Sabbagh Omar N., Sergott Robert C. Thrombocytosis in patients with biopsy-proven giant cell arteritis. Ophthalmology. 2002 Jul;109(7):1267–1271. doi: 10.1016/s0161-6420(02)01076-x. [DOI] [PubMed] [Google Scholar]
  36. Foroozan Rod, Deramo Vincent A., Buono Lawrence M., Jayamanne D. Gerard R., Sergott Robert C., Danesh-Meyer Helen, Savino Peter J. Recovery of visual function in patients with biopsy-proven giant cell arteritis. Ophthalmology. 2003 Mar;110(3):539–542. doi: 10.1016/S0161-6420(02)01775-X. [DOI] [PubMed] [Google Scholar]
  37. Fruchter Oren, Ben-Ami Haim, Schapira Daniel, Gallimidi Zahava, Gaitini Diana, Goldsher Dorit. Giant cell arteritis complicated by spinal cord infarction: a therapeutic dilemma. J Rheumatol. 2002 Jul;29(7):1556–1558. [PubMed] [Google Scholar]
  38. Gabriel S. E., Espy M., Erdman D. D., Bjornsson J., Smith T. F., Hunder G. G. The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation. Arthritis Rheum. 1999 Jun;42(6):1255–1258. doi: 10.1002/1529-0131(199906)42:6<1255::AID-ANR23>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  39. Gabriel S. E., O'Fallon W. M., Achkar A. A., Lie J. T., Hunder G. G. The use of clinical characteristics to predict the results of temporal artery biopsy among patients with suspected giant cell arteritis. J Rheumatol. 1995 Jan;22(1):93–96. [PubMed] [Google Scholar]
  40. García Vázquez J. M., Carreira J. M., Seoane C., Vidal J. J. Superior and inferior limb ischaemia in giant cell arteritis: angiography follow-up. Clin Rheumatol. 1999;18(1):61–65. doi: 10.1007/s100670050056. [DOI] [PubMed] [Google Scholar]
  41. Gertz M. A., Kyle R. A., Griffing W. L., Hunder G. G. Jaw claudication in primary systemic amyloidosis. Medicine (Baltimore) 1986 May;65(3):173–179. doi: 10.1097/00005792-198605000-00005. [DOI] [PubMed] [Google Scholar]
  42. Goldberg R. T. Ocular muscle paresis and cranial arteritis--an unusual case. Ann Ophthalmol. 1983 Mar;15(3):240–243. [PubMed] [Google Scholar]
  43. Gonzalez-Gay M. A., Garcia-Porrua C., Llorca J., Gonzalez-Louzao C., Rodriguez-Ledo P. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum. 2001 Feb;30(4):249–256. doi: 10.1053/sarh.2001.16650. [DOI] [PubMed] [Google Scholar]
  44. González-Gay M. A., Blanco R., Abraira V., García-Porrúa C., Ibáez D., García-Pais M. J., Rigueiro M. T., Sánchez-Andrade A., Guerrero J., Casariego E. Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. J Rheumatol. 1997 Nov;24(11):2171–2176. [PubMed] [Google Scholar]
  45. González-Gay M. A., Blanco R., Rodríguez-Valverde V., Martínez-Taboada V. M., Delgado-Rodriguez M., Figueroa M., Uriarte E. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum. 1998 Aug;41(8):1497–1504. doi: 10.1002/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  46. González-Gay M. A., Garcia-Porrua C., Rivas M. J., Rodriguez-Ledo P., Llorca J. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period. Ann Rheum Dis. 2001 Apr;60(4):367–371. doi: 10.1136/ard.60.4.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. González-Gay M. A., García-Porrúa C., Llorca J., Hajeer A. H., Brañas F., Dababneh A., González-Louzao C., Rodriguez-Gil E., Rodríguez-Ledo P., Ollier W. E. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 2000 Sep;79(5):283–292. doi: 10.1097/00005792-200009000-00001. [DOI] [PubMed] [Google Scholar]
  48. González-Gay M. A., García-Porrúa C. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects. Medicine (Baltimore) 1999 Sep;78(5):292–308. doi: 10.1097/00005792-199909000-00002. [DOI] [PubMed] [Google Scholar]
  49. González-Gay M. A., García-Porrúa C., Vázquez-Caruncho M. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheumatol. 1998 Sep;25(9):1750–1755. [PubMed] [Google Scholar]
  50. Goodman B. W., Jr, Shepard F. A. Jaw claudication. Its value as a diagnostic clue. Postgrad Med. 1983 Feb;73(2):177–183. doi: 10.1080/00325481.1983.11697764. [DOI] [PubMed] [Google Scholar]
  51. Govil Y. K., Sabanathan K., Scott D. Giant cell arteritis presenting as renal vasculitis. Postgrad Med J. 1998 Mar;74(869):170–171. doi: 10.1136/pgmj.74.869.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Gran J. T., Myklebust G. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987-94. J Rheumatol. 1997 Sep;24(9):1739–1743. [PubMed] [Google Scholar]
  53. Gran J. T., Myklebust G., Wilsgaard T., Jacobsen B. K. Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatology (Oxford) 2001 Nov;40(11):1238–1242. doi: 10.1093/rheumatology/40.11.1238. [DOI] [PubMed] [Google Scholar]
  54. Généreau T., Lortholary O., Guillevin L., Cacoub P., Galezowski N., Chérin P., Babinet P., Herreman G., Wechsler B., Cohen P. Temporal 67gallium uptake is increased in temporal arteritis. Rheumatology (Oxford) 1999 Aug;38(8):709–713. doi: 10.1093/rheumatology/38.8.709. [DOI] [PubMed] [Google Scholar]
  55. Hachulla E., Boivin V., Pasturel-Michon U., Fauchais A. L., Bouroz-Joly J., Perez-Cousin M., Hatron P. Y., Devulder B. Prognostic factors and long-term evolution in a cohort of 133 patients with giant cell arteritis. Clin Exp Rheumatol. 2001 Mar-Apr;19(2):171–176. [PubMed] [Google Scholar]
  56. Haga H. J., Eide G. E., Brun J., Johansen A., Langmark F. Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol. 1993 Aug;20(8):1335–1339. [PubMed] [Google Scholar]
  57. Hall Jennifer K., Volpe Nicholas J., Galetta Steven L., Liu Grant T., Syed Nasreen A., Balcer Laura J. The role of unilateral temporal artery biopsy. Ophthalmology. 2003 Mar;110(3):543–548. doi: 10.1016/S0161-6420(02)01758-X. [DOI] [PubMed] [Google Scholar]
  58. Hall S., Hunder G. G. Is temporal artery biopsy prudent? Mayo Clin Proc. 1984 Nov;59(11):793–796. doi: 10.1016/s0025-6196(12)65593-1. [DOI] [PubMed] [Google Scholar]
  59. Hayreh S. S., Podhajsky P. A., Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol. 1998 Apr;125(4):509–520. doi: 10.1016/s0002-9394(99)80192-5. [DOI] [PubMed] [Google Scholar]
  60. Hayreh Sohan Singh, Zimmerman Bridget, Kardon Randy H. Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature. Acta Ophthalmol Scand. 2002 Aug;80(4):355–367. doi: 10.1034/j.1600-0420.2002.800403.x. [DOI] [PubMed] [Google Scholar]
  61. Hernández-Rodríguez José, García-Martínez Ana, Casademont Jordi, Filella Xavier, Esteban María-José, López-Soto Alfonso, Fernández-Solà Joaquim, Urbano-Márquez Alvaro, Grau Josep M., Cid Maria C. A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis. Arthritis Rheum. 2002 Feb;47(1):29–35. doi: 10.1002/art1.10161. [DOI] [PubMed] [Google Scholar]
  62. Hoffman Gary S., Cid Maria C., Hellmann David B., Guillevin Loic, Stone John H., Schousboe John, Cohen Pascal, Calabrese Leonard H., Dickler Howard, Merkel Peter A. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 2002 May;46(5):1309–1318. doi: 10.1002/art.10262. [DOI] [PubMed] [Google Scholar]
  63. Hunder G. G., Bloch D. A., Michel B. A., Stevens M. B., Arend W. P., Calabrese L. H., Edworthy S. M., Fauci A. S., Leavitt R. Y., Lie J. T. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990 Aug;33(8):1122–1128. doi: 10.1002/art.1780330810. [DOI] [PubMed] [Google Scholar]
  64. Hunder G. G. Giant cell arteritis in polymyalgia rheumatica. Am J Med. 1997 Jun;102(6):514–516. [PubMed] [Google Scholar]
  65. Huong D. Le Thi, Andreu M. R., Duhaut P., Godeau P., Piette J. C. Intra-alveolar haemorrhage in temporal arteritis. Ann Rheum Dis. 2003 Feb;62(2):189–190. doi: 10.1136/ard.62.2.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Huston K. A., Hunder G. G., Lie J. T., Kennedy R. H., Elveback L. R. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978 Feb;88(2):162–167. doi: 10.7326/0003-4819-88-2-162. [DOI] [PubMed] [Google Scholar]
  67. Jover J. A., Hernández-García C., Morado I. C., Vargas E., Bañares A., Fernández-Gutiérrez B. Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2001 Jan 16;134(2):106–114. doi: 10.7326/0003-4819-134-2-200101160-00010. [DOI] [PubMed] [Google Scholar]
  68. Kyle V., Hazleman B. L. The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment. Ann Rheum Dis. 1993 Dec;52(12):847–850. doi: 10.1136/ard.52.12.847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Kyle V. Treatment of polymyalgia rheumatica/giant cell arteritis. Baillieres Clin Rheumatol. 1991 Dec;5(3):485–491. doi: 10.1016/s0950-3579(05)80067-6. [DOI] [PubMed] [Google Scholar]
  70. Landrin I., Chassagne P., Bouaniche M., Dominique S., Doucet J., Nouvet G., Bercoff E. Pulmonary artery thrombosis in giant cell arteritis. A new case and review of literature. Ann Med Interne (Paris) 1997;148(4):315–316. [PubMed] [Google Scholar]
  71. Le Hello C., Lévesque H., Jeanton M., Cailleux N., Galateau F., Peillon C., Veyssier P., Watelet J., Letellier P., Courtois H. Lower limb giant cell arteritis and temporal arteritis: followup of 8 cases. J Rheumatol. 2001 Jun;28(6):1407–1412. [PubMed] [Google Scholar]
  72. LeSar Christopher J., Meier George H., DeMasi Richard J., Sood Jaideep, Nelms Courtney R., Carter Kathleen A., Gayle Robert G., Parent F. Noel, Marcinczyk Michael J. The utility of color duplex ultrasonography in the diagnosis of temporal arteritis. J Vasc Surg. 2002 Dec;36(6):1154–1160. doi: 10.1067/mva.2002.129648. [DOI] [PubMed] [Google Scholar]
  73. Lie J. T. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum. 1995 Jun;24(6):422–431. doi: 10.1016/s0049-0172(95)80010-7. [DOI] [PubMed] [Google Scholar]
  74. Liozon E., Herrmann F., Ly K., Robert P. Y., Loustaud V., Soria P., Vidal E. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med. 2001 Aug 15;111(3):211–217. doi: 10.1016/s0002-9343(01)00770-7. [DOI] [PubMed] [Google Scholar]
  75. Liozon E., Roblot P., Paire D., Loustaud V., Liozon F., Vidal E., Jauberteau M. O. Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases. Rheumatology (Oxford) 2000 Oct;39(10):1089–1094. doi: 10.1093/rheumatology/39.10.1089. [DOI] [PubMed] [Google Scholar]
  76. Machado E. B., Michet C. J., Ballard D. J., Hunder G. G., Beard C. M., Chu C. P., O'Fallon W. M. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum. 1988 Jun;31(6):745–749. doi: 10.1002/art.1780310607. [DOI] [PubMed] [Google Scholar]
  77. Martinez-Taboada V. M., Blanco R., Fito C., Pacheco M. J., Delgado-Rodriguez M., Rodriguez-Valverde V. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review. Semin Arthritis Rheum. 2001 Feb;30(4):257–271. doi: 10.1053/sarh.2001.9734. [DOI] [PubMed] [Google Scholar]
  78. Martínez-Taboada V. M., Blanco R., Armona J., Uriarte E., Figueroa M., Gonzalez-Gay M. A., Rodriguez-Valverde V. Giant cell arteritis with an erythrocyte sedimentation rate lower than 50. Clin Rheumatol. 2000;19(1):73–75. doi: 10.1007/s100670050017. [DOI] [PubMed] [Google Scholar]
  79. Matteson E. L., Gold K. N., Bloch D. A., Hunder G. G. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med. 1996 Feb;100(2):193–196. doi: 10.1016/s0002-9343(97)89458-2. [DOI] [PubMed] [Google Scholar]
  80. Medvedev George, Al-Shamari Ali E. R., Copland Michael A., Magil Alex B. Isolated renal giant cell arteritis. Am J Kidney Dis. 2002 Sep;40(3):658–661. doi: 10.1053/ajkd.2002.34931. [DOI] [PubMed] [Google Scholar]
  81. Myklebust Geirmund, Wilsgaard Tom, Jacobsen Bjarne Koster, Gran Jan Tore. No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls. J Rheumatol. 2002 Oct;29(10):2143–2147. [PubMed] [Google Scholar]
  82. Nesher G., Rubinow A., Sonnenblick M. Efficacy and adverse effects of different corticosteroid dose regimens in temporal arteritis: a retrospective study. Clin Exp Rheumatol. 1997 May-Jun;15(3):303–306. [PubMed] [Google Scholar]
  83. Nesher G., Sonnenblick M., Friedlander Y. Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients. J Rheumatol. 1994 Jul;21(7):1283–1286. [PubMed] [Google Scholar]
  84. Nesher G., Sonnenblick M. Steroid-sparing medications in temporal arteritis--report of three cases and review of 174 reported patients. Clin Rheumatol. 1994 Jun;13(2):289–292. doi: 10.1007/BF02249029. [DOI] [PubMed] [Google Scholar]
  85. Nesher Gideon, Shemesh David, Mates Michal, Sonnenblick Moshe, Abramowitz Harry B. The predictive value of the halo sign in color Doppler ultrasonography of the temporal arteries for diagnosing giant cell arteritis. J Rheumatol. 2002 Jun;29(6):1224–1226. [PubMed] [Google Scholar]
  86. Nir-Paz R., Gross A., Chajek-Shaul T. Reduction of jaw opening (trismus) in giant cell arteritis. Ann Rheum Dis. 2002 Sep;61(9):832–833. doi: 10.1136/ard.61.9.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Pascuzzi R. M., Roos K. L., Davis T. E., Jr Mental status abnormalities in temporal arteritis: a treatable cause of dementia in the elderly. Arthritis Rheum. 1989 Oct;32(10):1308–1311. doi: 10.1002/anr.1780321017. [DOI] [PubMed] [Google Scholar]
  88. Patterson A., Scully C., Barnard N., Griffiths M. J., Eveson J. W., Novelli M. Necrosis of the tongue in a patient with intestinal infarction. Oral Surg Oral Med Oral Pathol. 1992 Nov;74(5):582–586. doi: 10.1016/0030-4220(92)90348-t. [DOI] [PubMed] [Google Scholar]
  89. Paulley J. W. Coronary ischaemia and occlusion in giant cell (temporal) arteritis. Acta Med Scand. 1980;208(4):257–263. doi: 10.1111/j.0954-6820.1980.tb01190.x. [DOI] [PubMed] [Google Scholar]
  90. Ray-Chaudhuri N., Kiné D. Ah, Tijani S. O., Parums D. V., Cartlidge N., Strong N. P., Dayan M. R. Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthalmol. 2002 May;86(5):530–532. doi: 10.1136/bjo.86.5.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Reich K. A., Giansiracusa D. F., Strongwater S. L. Neurologic manifestations of giant cell arteritis. Am J Med. 1990 Jul;89(1):67–72. doi: 10.1016/0002-9343(90)90100-r. [DOI] [PubMed] [Google Scholar]
  92. Rimenti G., Blasi F., Cosentini R., Moling O., Pristerà R., Tarsia P., Vedovelli C., Mian P. Temporal arteritis associated with Chlamydia pneumoniae DNA detected in an artery specimen. J Rheumatol. 2000 Nov;27(11):2718–2720. [PubMed] [Google Scholar]
  93. Rodriguez-Valverde V., Sarabia J. M., González-Gay M. A., Figueroa M., Armona J., Blanco R., Fernández-Sueiro J. L., Martínez-Taboada V. M. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica. Am J Med. 1997 Apr;102(4):331–336. doi: 10.1016/s0002-9343(97)00117-4. [DOI] [PubMed] [Google Scholar]
  94. Rüegg Stephan, Engelter Stefan, Jeanneret Christine, Hetzel Andreas, Probst Alphonse, Steck Andreas J., Lyrer Philippe. Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature. Medicine (Baltimore) 2003 Jan;82(1):1–12. doi: 10.1097/00005792-200301000-00001. [DOI] [PubMed] [Google Scholar]
  95. Salvarani C., Gabriel S. E., O'Fallon W. M., Hunder G. G. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med. 1995 Aug 1;123(3):192–194. doi: 10.7326/0003-4819-123-3-199508010-00006. [DOI] [PubMed] [Google Scholar]
  96. Salvarani C., Hunder G. G. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study. Arthritis Rheum. 2001 Apr;45(2):140–145. doi: 10.1002/1529-0131(200104)45:2<140::AID-ANR166>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  97. Salvarani C., Macchioni P., Zizzi F., Mantovani W., Rossi F., Castri C., Capozzoli N., Baricchi R., Boiardi L., Chiaravalloti F. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum. 1991 Mar;34(3):351–356. doi: 10.1002/art.1780340313. [DOI] [PubMed] [Google Scholar]
  98. Salvarani Carlo, Cantini Fabrizio, Boiardi Luigi, Hunder Gene G. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002 Jul 25;347(4):261–271. doi: 10.1056/NEJMra011913. [DOI] [PubMed] [Google Scholar]
  99. Salvarani Carlo, Silingardi Mauro, Ghirarduzzi Angelo, Lo Scocco Giovanni, Macchioni PierLuigi, Bajocchi GianLuigi, Vinceti Marco, Cantini Fabrizio, Iori Ido, Boiardi Luigi. Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis?. Ann Intern Med. 2002 Aug 20;137(4):232–238. doi: 10.7326/0003-4819-137-4-200208200-00006. [DOI] [PubMed] [Google Scholar]
  100. Sandercock P. A., Warlow C. P., Jones L. N., Starkey I. R. Predisposing factors for cerebral infarction: the Oxfordshire community stroke project. BMJ. 1989 Jan 14;298(6666):75–80. doi: 10.1136/bmj.298.6666.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Soderstrom C. W., Seehafer J. R. Bilateral scalp necrosis in temporal arteritis. A rare complication of Horton's disease. Am J Med. 1976 Oct;61(4):541–546. doi: 10.1016/0002-9343(76)90335-1. [DOI] [PubMed] [Google Scholar]
  102. Sonnenblick M., Nesher G., Friedlander Y., Rubinow A. Giant cell arteritis in Jerusalem: a 12-year epidemiological study. Br J Rheumatol. 1994 Oct;33(10):938–941. doi: 10.1093/rheumatology/33.10.938. [DOI] [PubMed] [Google Scholar]
  103. Speed C. A., Haslock I. Polymyalgia rheumatica, temporal arteritis and malignancy. Postgrad Med J. 1995 Aug;71(838):500–502. doi: 10.1136/pgmj.71.838.500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Spiera R. F., Mitnick H. J., Kupersmith M., Richmond M., Spiera H., Peterson M. G., Paget S. A. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol. 2001 Sep-Oct;19(5):495–501. [PubMed] [Google Scholar]
  105. Staunton H., Stafford F., Leader M., O'Riordain D. Deterioration of giant cell arteritis with corticosteroid therapy. Arch Neurol. 2000 Apr;57(4):581–584. doi: 10.1001/archneur.57.4.581. [DOI] [PubMed] [Google Scholar]
  106. Strady Christophe, Arav Eric, Strady Alain, Jaussaud Roland, Beguinot Isabelle, Rouger Christine, Pluot Michel, Remy Gérard. Valeur diagnostique des signes de la maladie de Horton. Ann Med Interne (Paris) 2002 Feb;153(1):3–12. [PubMed] [Google Scholar]
  107. Sudlow C. Diagnosing and managing polymyalgia rheumatica and temporal arteritis. Sensitivity of temporal artery biopsy varies with biopsy length and sectioning strategy. BMJ. 1997 Aug 30;315(7107):549–549. [PMC free article] [PubMed] [Google Scholar]
  108. Takahashi I., Takamura H., Gotoh S., Sasaki H., Ishikawa T. Giant cell arteritis with subarachnoid haemorrhage due to the rupture of inflammatory aneurysm of the posterior inferior cerebellar artery. Acta Neurochir (Wien) 1996;138(7):893–894. doi: 10.1007/BF01411272. [DOI] [PubMed] [Google Scholar]
  109. Tan A. L., Holdsworth J., Pease C., Emery P., McGonagle D. Successful treatment of resistant giant cell arteritis with etanercept. Ann Rheum Dis. 2003 Apr;62(4):373–374. doi: 10.1136/ard.62.4.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Tovilla-Canales J. L. Ocular manifestations of giant cell arteritis. Curr Opin Ophthalmol. 1998 Dec;9(6):73–79. doi: 10.1097/00055735-199812000-00013. [DOI] [PubMed] [Google Scholar]
  111. Turlakow A., Yeung H. W., Pui J., Macapinlac H., Liebovitz E., Rusch V., Goy A., Larson S. M. Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. Arch Intern Med. 2001 Apr 9;161(7):1003–1007. doi: 10.1001/archinte.161.7.1003. [DOI] [PubMed] [Google Scholar]
  112. Uddhammar Agneta, Eriksson Anna-Lena, Nyström Lennarth, Stenling Roger, Rantapä-Dahlqvist Solbritt. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol. 2002 Apr;29(4):737–742. [PubMed] [Google Scholar]
  113. Vanderschueren S., Depoot I., Knockaert D. C., Verbeken E. K., Zaman Z., Bobbaers H. Microscopic haematuria in giant cell arteritis. Clin Rheumatol. 2002 Sep;21(5):373–377. doi: 10.1007/s100670200100. [DOI] [PubMed] [Google Scholar]
  114. Venna N., Goldman R., Tilak S., Sabin T. D. Temporal arteritis-like presentation of carotid atherosclerosis. Stroke. 1986 Mar-Apr;17(2):325–327. doi: 10.1161/01.str.17.2.325. [DOI] [PubMed] [Google Scholar]
  115. Vermeulen J. P., Mahowald M. L. A case of Wegener's granulomatosis presenting with jaw claudication. J Rheumatol. 1984 Oct;11(5):707–709. [PubMed] [Google Scholar]
  116. Wagner A. D., Gérard H. C., Fresemann T., Schmidt W. A., Gromnica-Ihle E., Hudson A. P., Zeidler H. Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells. Arthritis Rheum. 2000 Jul;43(7):1543–1551. doi: 10.1002/1529-0131(200007)43:7<1543::AID-ANR19>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  117. Weyand C. M., Fulbright J. W., Hunder G. G., Evans J. M., Goronzy J. J. Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity. Arthritis Rheum. 2000 May;43(5):1041–1048. doi: 10.1002/1529-0131(200005)43:5<1041::AID-ANR12>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  118. Weyand C. M., Hicok K. C., Hunder G. G., Goronzy J. J. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med. 1994 Oct 1;121(7):484–491. doi: 10.7326/0003-4819-121-7-199410010-00003. [DOI] [PubMed] [Google Scholar]
  119. Weyand C. M., Tetzlaff N., Björnsson J., Brack A., Younge B., Goronzy J. J. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum. 1997 Jan;40(1):19–26. doi: 10.1002/art.1780400105. [DOI] [PubMed] [Google Scholar]
  120. Weyand Cornelia M., Kaiser Markus, Yang Hongyu, Younge Brian, Goronzy Jörg J. Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis Rheum. 2002 Feb;46(2):457–466. doi: 10.1002/art.10071. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES